Colchicine
2023-GSP-GG-32
Approved small_molecule active
Quick answer
Colchicine for In-stent Restenosis is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- In-stent Restenosis
- Phase
- Approved
- Modality
- small_molecule
- Status
- active